Literature DB >> 17196462

Diagnostic and prognostic value of a type 1 Brugada electrocardiogram at higher (third or second) V1 to V2 recording in men with Brugada syndrome.

Koji Miyamoto1, Miki Yokokawa, Koji Tanaka, Takayuki Nagai, Hideo Okamura, Takashi Noda, Kazuhiro Satomi, Kazuhiro Suyama, Takashi Kurita, Naohiko Aihara, Shiro Kamakura, Wataru Shimizu.   

Abstract

To evaluate the diagnostic and prognostic value of an electrocardiogram (ECG) recorded at a higher (third or second) intercostal space, 98 men (17 to 76 years of age, mean +/- SD 47 +/- 13; with documented ventricular fibrillation [VF] in 22 and syncope in 32) were categorized into 3 groups; 68 men had a spontaneous type 1 ECG in standard leads V(1) and V(2) (S group), 19 had a spontaneous type 1 ECG only in the higher V(1) and V(2) leads (H group), and 11 had a type 1 ECG only after receiving class Ic sodium channel blockers (Ic group). There were no significant differences in baseline clinical characteristics, including VF episodes, syncope, atrial fibrillation, family history, late potentials, and inducibility of VF during electrophysiologic study across the 3 groups. During prospective follow-up periods (779 +/- 525, 442 +/- 282, and 573 +/- 382 days, respectively), subsequent cardiac events occurred in 11 men (16%) within the S group, in 2 men (11%) in the H group, and in 0 men (0%) in the Ic group (p = NS, S vs H group). In men with previous episodes of VF, subsequent cardiac events occurred in 7 (44%) within the S group and in 2 (50%) in the H group (p = NS). In conclusion, men with a spontaneous type 1 Brugada ECG recorded only at higher leads V(1) and V(2) showed a prognosis similar to that of men with a type 1 ECG in using standard leads V(1) and V(2).

Entities:  

Mesh:

Year:  2006        PMID: 17196462     DOI: 10.1016/j.amjcard.2006.07.062

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  24 in total

1.  Detection of a type 1 Brugada ECG by ECG recording at a higher intercostal space of leads V(1) and V (2).

Authors:  Thomas Butz; Jürgen Vogt; Christian Vielhauer; Ulrike Wetzel; Christoph Langer; Dieter Horstkotte
Journal:  Herz       Date:  2010-03       Impact factor: 1.443

Review 2.  J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Authors:  Charles Antzelevitch; Gan-Xin Yan; Michael J Ackerman; Martin Borggrefe; Domenico Corrado; Jihong Guo; Ihor Gussak; Can Hasdemir; Minoru Horie; Heikki Huikuri; Changsheng Ma; Hiroshi Morita; Gi-Byoung Nam; Frederic Sacher; Wataru Shimizu; Sami Viskin; Arthur A M Wilde
Journal:  Europace       Date:  2017-04-01       Impact factor: 5.214

3.  The KCNJ8-S422L variant previously associated with J-wave syndromes is found at an increased frequency in Ashkenazi Jews.

Authors:  Krishna R Veeramah; Tatiana M Karafet; Daniel Wolf; Ricardo A Samson; Michael F Hammer
Journal:  Eur J Hum Genet       Date:  2013-05-01       Impact factor: 4.246

Review 4.  J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Authors:  Charles Antzelevitch; Gan-Xin Yan; Michael J Ackerman; Martin Borggrefe; Domenico Corrado; Jihong Guo; Ihor Gussak; Can Hasdemir; Minoru Horie; Heikki Huikuri; Changsheng Ma; Hiroshi Morita; Gi-Byoung Nam; Frederic Sacher; Wataru Shimizu; Sami Viskin; Arthur A M Wilde
Journal:  Heart Rhythm       Date:  2016-07-13       Impact factor: 6.343

Review 5.  The Brugada Syndrome - Diagnosis, Clinical Implications and Risk Stratification.

Authors:  Velislav N Batchvarov
Journal:  Eur Cardiol       Date:  2014-12

Review 6.  Pathogenesis and management of Brugada syndrome.

Authors:  Juan Sieira; Gregory Dendramis; Pedro Brugada
Journal:  Nat Rev Cardiol       Date:  2016-09-15       Impact factor: 32.419

Review 7.  Atrial fibrillation and Brugada syndrome.

Authors:  Johnson Francis; Charles Antzelevitch
Journal:  J Am Coll Cardiol       Date:  2008-03-25       Impact factor: 24.094

8.  2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families.

Authors:  Martin K Stiles; Arthur A M Wilde; Dominic J Abrams; Michael J Ackerman; Christine M Albert; Elijah R Behr; Sumeet S Chugh; Martina C Cornel; Karen Gardner; Jodie Ingles; Cynthia A James; Jyh-Ming Jimmy Juang; Stefan Kääb; Elizabeth S Kaufman; Andrew D Krahn; Steven A Lubitz; Heather MacLeod; Carlos A Morillo; Koonlawee Nademanee; Vincent Probst; Elizabeth V Saarel; Luciana Sacilotto; Christopher Semsarian; Mary N Sheppard; Wataru Shimizu; Jonathan R Skinner; Jacob Tfelt-Hansen; Dao Wu Wang
Journal:  Heart Rhythm       Date:  2020-10-19       Impact factor: 6.343

9.  Brugada syndrome with elevated cardiac biomarkers.

Authors:  Fatima AlKendi; Mujgan Jamil; Anwer Qureshi; Gohar Jamil
Journal:  BMJ Case Rep       Date:  2013-06-27

Review 10.  Risk stratification and treatment of brugada syndrome.

Authors:  Elena Arbelo; Josep Brugada
Journal:  Curr Cardiol Rep       Date:  2014-07       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.